vs

Side-by-side financial comparison of Churchill Downs Inc (CHDN) and CLOVER HEALTH INVESTMENTS, CORP. (CLOV). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($749.2M vs $663.0M, roughly 1.1× Churchill Downs Inc). Churchill Downs Inc runs the higher net margin — 12.5% vs 3.6%, a 8.9% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (62.0% vs 3.1%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (45.0% CAGR vs -13.7%).

Churchill Downs Incorporated is the parent company of Churchill Downs. The company has evolved from one racetrack in Louisville, Kentucky, to a multi American-state-wide, publicly traded company with racetracks, casinos and an online wagering company among its portfolio of businesses.

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

CHDN vs CLOV — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.1× larger
CLOV
$749.2M
$663.0M
CHDN
Growing faster (revenue YoY)
CLOV
CLOV
+58.9% gap
CLOV
62.0%
3.1%
CHDN
Higher net margin
CHDN
CHDN
8.9% more per $
CHDN
12.5%
3.6%
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
45.0%
-13.7%
CHDN

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CHDN
CHDN
CLOV
CLOV
Revenue
$663.0M
$749.2M
Net Profit
$83.0M
$27.3M
Gross Margin
Operating Margin
21.6%
3.6%
Net Margin
12.5%
3.6%
Revenue YoY
3.1%
62.0%
Net Profit YoY
7.8%
EPS (diluted)
$1.16
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CHDN
CHDN
CLOV
CLOV
Q1 26
$663.0M
$749.2M
Q4 25
$665.9M
$487.7M
Q3 25
$683.0M
$496.6M
Q2 25
$934.4M
$477.6M
Q1 25
$642.6M
$462.3M
Q4 24
$624.2M
$337.0M
Q3 24
$628.5M
$331.0M
Q2 24
$890.7M
$356.3M
Net Profit
CHDN
CHDN
CLOV
CLOV
Q1 26
$83.0M
$27.3M
Q4 25
$51.3M
$-49.3M
Q3 25
$38.1M
$-24.4M
Q2 25
$216.9M
$-10.6M
Q1 25
$76.7M
$-1.3M
Q4 24
$71.7M
$-22.1M
Q3 24
$65.4M
$-9.2M
Q2 24
$209.3M
$7.4M
Gross Margin
CHDN
CHDN
CLOV
CLOV
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
24.5%
Q2 24
30.3%
Operating Margin
CHDN
CHDN
CLOV
CLOV
Q1 26
21.6%
3.6%
Q4 25
18.5%
-10.1%
Q3 25
14.3%
-4.9%
Q2 25
35.1%
-2.2%
Q1 25
20.9%
-0.3%
Q4 24
20.3%
-6.4%
Q3 24
20.0%
-2.7%
Q2 24
37.0%
2.0%
Net Margin
CHDN
CHDN
CLOV
CLOV
Q1 26
12.5%
3.6%
Q4 25
7.7%
-10.1%
Q3 25
5.6%
-4.9%
Q2 25
23.2%
-2.2%
Q1 25
11.9%
-0.3%
Q4 24
11.5%
-6.6%
Q3 24
10.4%
-2.8%
Q2 24
23.5%
2.1%
EPS (diluted)
CHDN
CHDN
CLOV
CLOV
Q1 26
$1.16
$0.05
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CHDN
CHDN
CLOV
CLOV
Cash + ST InvestmentsLiquidity on hand
$200.0M
$177.6M
Total DebtLower is stronger
$840.0M
Stockholders' EquityBook value
$339.4M
Total Assets
$7.5B
$697.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CHDN
CHDN
CLOV
CLOV
Q1 26
$200.0M
$177.6M
Q4 25
$200.6M
$78.3M
Q3 25
$180.5M
Q2 25
$182.4M
Q1 25
$174.2M
Q4 24
$175.5M
$194.5M
Q3 24
$152.7M
$288.0M
Q2 24
$140.3M
$254.8M
Total Debt
CHDN
CHDN
CLOV
CLOV
Q1 26
$840.0M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CHDN
CHDN
CLOV
CLOV
Q1 26
$339.4M
Q4 25
$1.0B
$308.7M
Q3 25
$1.0B
$340.9M
Q2 25
$1.0B
$344.2M
Q1 25
$1.1B
$336.1M
Q4 24
$1.1B
$341.1M
Q3 24
$1.1B
$342.2M
Q2 24
$1.0B
$324.9M
Total Assets
CHDN
CHDN
CLOV
CLOV
Q1 26
$7.5B
$697.7M
Q4 25
$7.5B
$541.0M
Q3 25
$7.5B
$559.7M
Q2 25
$7.4B
$575.0M
Q1 25
$7.3B
$583.7M
Q4 24
$7.3B
$580.7M
Q3 24
$7.2B
$653.0M
Q2 24
$7.2B
$674.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CHDN
CHDN
CLOV
CLOV
Operating Cash FlowLast quarter
$295.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
3.55×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CHDN
CHDN
CLOV
CLOV
Q1 26
$295.0M
Q4 25
$-66.9M
Q3 25
$187.7M
$12.1M
Q2 25
$5.4M
Q1 25
$246.5M
$-16.3M
Q4 24
$34.8M
Q3 24
$169.4M
$50.0M
Q2 24
$44.8M
Free Cash Flow
CHDN
CHDN
CLOV
CLOV
Q1 26
Q4 25
$-69.0M
Q3 25
$166.3M
$11.4M
Q2 25
$4.8M
Q1 25
$233.9M
$-16.5M
Q4 24
$33.3M
Q3 24
$154.4M
$49.6M
Q2 24
$44.4M
FCF Margin
CHDN
CHDN
CLOV
CLOV
Q1 26
Q4 25
-14.1%
Q3 25
24.3%
2.3%
Q2 25
1.0%
Q1 25
36.4%
-3.6%
Q4 24
9.9%
Q3 24
24.6%
15.0%
Q2 24
12.5%
Capex Intensity
CHDN
CHDN
CLOV
CLOV
Q1 26
Q4 25
2.6%
0.4%
Q3 25
3.1%
0.1%
Q2 25
2.0%
0.1%
Q1 25
2.0%
0.0%
Q4 24
5.4%
0.5%
Q3 24
2.4%
0.1%
Q2 24
2.5%
0.1%
Cash Conversion
CHDN
CHDN
CLOV
CLOV
Q1 26
3.55×
Q4 25
Q3 25
4.93×
Q2 25
Q1 25
3.21×
Q4 24
Q3 24
2.59×
Q2 24
6.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CHDN
CHDN

Live and Historical Racing$297.0M45%
Gaming$257.0M39%
Wagering Services and Solutions$109.0M16%

CLOV
CLOV

Segment breakdown not available.

Related Comparisons